Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Tandem Diabetes Care missed estimated earnings by 228.57%, reporting an EPS of $-0.23 versus an estimate of $-0.07.
Revenue was up $34.87 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 1.84% drop in the share price the next day.
Here's a look at Tandem Diabetes Care's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.21 | 0.06 | -0.08 | -0.16 |
| EPS Actual | 0.16 | 0.09 | 0.06 | -0.08 |
| Revenue Estimate | 199.12M | 171.41M | 143.63M | 121.96M |
| Revenue Actual | 210.00M | 179.63M | 172.14M | 141.04M |
To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
